Clinical Trial Update: Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of glycerol phenylbutyrate as a potential cystic fibrosis therapy was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Glycerol phenylbutyrate (glycerol phenylbutyrate)

Snippet

Sponsor: National Jewish Health | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-04-17